Curia (formerly AMRI, Albany, NY) is a CDMO. 2024 revenue ~$1.1B. API synthesis, drug product, biologics. Acquired by GHO Capital (2023). Strong in complex small molecule synthesis and analytical development.
12:41:37 AM · Jul 9, 2026
Sign in to reply and join the conversation.